Zaman K - Search Results

1

Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor.

Scabia V, Ayyanan A, De Martino F, Agnoletto A, Battista L, Laszlo C, Treboux A, Zaman K, Stravodimou A, Jallut D, Fiche M, Bucher P, Ambrosini G, Sflomos G, Brisken C. Scabia V, et al. Among authors: zaman k. Nat Commun. 2022 Jun 6;13(1):3127. doi: 10.1038/s41467-022-30898-0. Nat Commun. 2022. PMID: 35668111 Free PMC article.

2

Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00).

Perey L, Paridaens R, Hawle H, Zaman K, Nolé F, Wildiers H, Fiche M, Dietrich D, Clément P, Köberle D, Goldhirsch A, Thürlimann B. Perey L, et al. Among authors: zaman k. Ann Oncol. 2007 Jan;18(1):64-69. doi: 10.1093/annonc/mdl341. Epub 2006 Oct 9. Ann Oncol. 2007. PMID: 17030543 Free article. Clinical Trial.

3

[Breast cancer: pathology, the cornerstone of therapeutic decision].

Fiche M, Lehr HA, Perey L, Delaloye JF, Jeanneret-Sozzi W, Bauer J, Zaman K. Fiche M, et al. Among authors: zaman k. Rev Med Suisse. 2007 Jul 18;3(119):1737-42. Rev Med Suisse. 2007. PMID: 17727094 Review. French.

4

Improving breast cancer education: the case of an evolving multidisciplinary module for undergraduate medical students (Lausanne Medical School, 1993-2008).

Fiche M, Lepori D, Guntern D, Jucker-Kupper P, Jeanneret W, Zaman K, Vadot S, Delaloye JF. Fiche M, et al. Among authors: zaman k. J Cancer Educ. 2010 Mar;25(1):101-5. doi: 10.1007/s13187-009-0022-0. J Cancer Educ. 2010. PMID: 20082176

5

The HER2 amplicon in breast cancer: Topoisomerase IIA and beyond.

Jacot W, Fiche M, Zaman K, Wolfer A, Lamy PJ. Jacot W, et al. Among authors: zaman k. Biochim Biophys Acta. 2013 Aug;1836(1):146-57. doi: 10.1016/j.bbcan.2013.04.004. Epub 2013 Apr 26. Biochim Biophys Acta. 2013. PMID: 23628726 Review.

6

Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series.

Stravodimou A, Zaman K, Voutsadakis IA. Stravodimou A, et al. Among authors: zaman k. ISRN Oncol. 2014 Mar 30;2014:289836. doi: 10.1155/2014/289836. eCollection 2014. ISRN Oncol. 2014. PMID: 25006504 Free PMC article.

7

[BRCA mutations: from Angelina Jolie to specific therapies].

Lopez VA, Stravodimou A, Unger S, Perey L, Zaman K. Lopez VA, et al. Among authors: zaman k. Rev Med Suisse. 2016 May 18;12(519):973-4, 976-7. Rev Med Suisse. 2016. PMID: 27424423 French.

8

[Hormone therapy in invasive breast cancer : update 2016].

Zurcher JP, Stravodimou A, Zaman K. Zurcher JP, et al. Among authors: zaman k. Rev Med Suisse. 2016 Sep 21;12(531):1580-1583. Rev Med Suisse. 2016. PMID: 28678454 French.

9

Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions.

Fiche M, Scabia V, Aouad P, Battista L, Treboux A, Stravodimou A, Zaman K; RLS; Dormoy V, Ayyanan A, Sflomos G, Brisken C. Fiche M, et al. Among authors: zaman k. J Pathol. 2019 Mar;247(3):287-292. doi: 10.1002/path.5200. Epub 2018 Dec 27. J Pathol. 2019. PMID: 30430577 Free PMC article.

10

[New therapeutic strategies in advanced stage breast and tubo-ovarian cancers].

Nikolopoulou A, Galli-Vareia I, Stravodimou A, Sarivalasis A, Zaman K. Nikolopoulou A, et al. Among authors: zaman k. Rev Med Suisse. 2019 May 15;15(651):1027-1031. Rev Med Suisse. 2019. PMID: 31091037 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

720 results

Search Page